Jefferson will become one of 48 centers in the world focused on Parkinson’s patient care, research, outreach and education, named by the Parkinson’s Foundation.

New research establishes link between mitochondria dysfunction and dopamine in PINK1 model of disease.

Jefferson researchers unveil first demonstration of heritable mutations behind non-alcoholic fatty liver disease.

The discovery supports GM1 ganglioside as a potential target for Parkinson's therapy.

Changing the route of entry for minimally invasive neurosurgery provides better outcomes for a wide range of interventions, and is preferred by patients.

Researchers identify changes in enzymes that may contribute to lung damage in rare genetic disorder

The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson’s Disease

New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.

Researchers aim to study how infections of the fetal membranes during pregnancy can increase risks for a number of serious newborn diseases. 

Prostate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive, metastatic stage